Nauzene
NDC Package 52389-172-04

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Nauzene is read all package directions and warnings before use and use only as directed.Adults:  1 - 2 tablespoons (15 - 30 mL).Children:  Consult a doctor for appropriate dosage.Dosage may be repeated after 30 minutes not to exceed 6 doses in a 24-hour period unless advised by a doctor.For maximum effectiveness never dilute Nauzene or drink fluids of any kind immediately before or after taking Nauzene.Nauzene Liquid is intended for use by normally healthy persons only.Persons under 18 years of age should use only as directed by a doctor. Marketed by Alva-amco Pharmacal Companies, Inc., this product is identified by NDC 52389-172 and is authorized under FDA application part357.

Identification & Billing

NDC Package Code
52389-172-04
Package Description
118 mL in 1 BOTTLE, PLASTIC
Product Code
52389-172
11-Digit Billing Format
52389017204
RxNorm Crosswalk
  • RxCUI: 895045 - glucose 4.35 GM / fructose 4.17 GM / sodium citrate 0.921 GM in 15 mL Oral Solution
  • RxCUI: 895045 - fructose 278 MG/ML / glucose 290 MG/ML / sodium citrate 61.4 MG/ML Oral Solution
  • RxCUI: 895045 - fructose 4.17 GM / glucose 4.35 GM / sodium citrate 0.921 GM per 15 ML Oral Solution

Clinical Specifications

Proprietary Name
Nauzene
Dosage Form
-
Usage Information
Read all package directions and warnings before use and use only as directed.Adults:  1 - 2 tablespoons (15 - 30 mL).Children:  Consult a doctor for appropriate dosage.Dosage may be repeated after 30 minutes not to exceed 6 doses in a 24-hour period unless advised by a doctor.For maximum effectiveness never dilute Nauzene or drink fluids of any kind immediately before or after taking Nauzene.Nauzene Liquid is intended for use by normally healthy persons only.Persons under 18 years of age should use only as directed by a doctor.

Regulatory & Marketing

Labeler Name
Alva-amco Pharmacal Companies, Inc.
FDA Application #
part357
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
02-15-2000
Listing Expiration
12-31-2018
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 52389-172-04 identifies a specific commercial package of 118 ml in 1 bottle, plastic of Nauzene, labeled by Alva-amco Pharmacal Companies, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Alva-amco Pharmacal Companies, Inc. on February 15, 2000. The current certification is valid through December 31, 2018.

How is this Alva-amco Pharmacal Companies, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 52389017204. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
52389-172-04
11-Digit CMS (5-4-2)
52389-0172-04

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.